Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.

Autor: England JT; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. james.england@mail.utoronto.ca.; Division of Medical Oncology & Malignant Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. james.england@mail.utoronto.ca., Szuber N; Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, QC, Canada., Sirhan S; Jewish General Hospital, McGill University, Montreal, QC, Canada., Dunne T; Division of Hematology, Newfoundland and Labrador Health Services, St. John's, NL, Canada., Cerquozzi S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Hill M; The Ottawa Hospital Research Institute, Ottawa, Ottawa, ON, Canada., Villeneuve PJA; The Ottawa Hospital Research Institute, Ottawa, Ottawa, ON, Canada.; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Ho JM; Division of Hematology, Department of Medicine, Western University, London Health Sciences Centre, London, ON, Canada., Sadikovic B; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada., Bhai P; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada., Krishnan N; Royal Victoria Regional Health Center, Barrie, ON, Canada., Dowhanik S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Hillis C; Department of Oncology, McMaster University, Hamilton, ON, Canada., Capo-Chichi JM; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Tsui H; Department of Hematopathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Cheung V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gauthier K; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Sibai H; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Davidson MB; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bankar A; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Kotchetkov R; Royal Victoria Regional Health Center, Barrie, ON, Canada., Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Maze D; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

Publikováno v: Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 570-578. Date of Electronic Publication: 2024 Feb 06.

Bendamustine and rituximab is well-tolerated and efficient in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma in elderly: A single center observational study.

Autor: Kotchetkov R; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada., Drennan IR; Department of Family and Community Medicine, Temerity Faculty of Medicine, Sunnybrook Research Institute, Sunnybrook Health Science Center, University of Toronto, Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Susman D; Western University, London, Ontario, Canada., DiMaria E; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada., Gerard L; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada., Nay D; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada., Prica A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.

Publikováno v: International journal of cancer [Int J Cancer] 2023 May 01; Vol. 152 (9), pp. 1884-1893. Date of Electronic Publication: 2022 Dec 30.

Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy.

Autor: Krishnan N; Department of Medical Sciences, University of Western Ontario, London, ON, Canada., Price R; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Centre, Barrie, ON, Canada., Kotchetkov R; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Centre, Barrie, ON, Canada.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Jun 08; Vol. 13, pp. 1213942. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).

Anticoagulation and bone marrow biopsy: is it safe to proceed?

Autor: Moore C; Royal Victoria Regional Health Centre, Barrie, Canada., Kotchetkov R; Royal Victoria Regional Health Centre, Barrie, Canada.

Publikováno v: Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 206-209.

Lymphocytosis with Smudge Cells Is Not Equivalent to Chronic Lymphocytic Leukemia.

Autor: Susman D; Department of Medicine, Western University, London, Ontario, Canada., Price R; Department of Pathology, Royal Victoria Regional Health Centre, Barrie, Ontario, Canada., Kotchetkov R; Department of Oncology, Royal Victoria Regional Health Centre, Barrie, Ontario, Canada.

Publikováno v: Case reports in oncology [Case Rep Oncol] 2021 Jun 18; Vol. 14 (2), pp. 950-956. Date of Electronic Publication: 2021 Jun 18 (Print Publication: 2021).